Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Cell Shrinkage as a Result of Raised Intracranial Pressure after Intracerebral Hemorrhage

EF 2020-21

Résumé
Intracerebral hemorrhage (ICH) is a devastating stroke subtype in which a blood vessel ruptures in the brain. Normally, the skull has three components: brain, blood, and cerebrospinal fluid (CSF), which must remain in equilibrium to maintain brain health. However, ICH results in bleeding and swelling in the brain. To maintain equilibrium after ICH, blood and CSF can be ""pushed"" out of the skull, reducing the amount of pressure. These ""compliance mechanisms"" help maintain normal intracranial pressure (ICP). When these mechanisms fail, ICP elevations can worsen outcome and increase the risk of death. Previously, brain tissue was not thought to play a role in ICP compensation. However, we have recently shown cell shrinkage (a decrease in the size of brain cells) following ICH, and we hypothesize that this is a previously uncharacterized compliance mechanism to blunt rises in ICP. Importantly, we have found evidence that this cell shrinkage can harm brain cells. Our goal is to test whether two clinically used methods of ICP reduction after stroke still result in cell shrinkage, and their impact on cellular health. First, we will reduce ICP with one clinical treatment. Since reducing ICP will reduce the pressure on shrinking cells, we expect to see less cell shrinkage after this treatment, and perhaps lessen or prevent injury to brain cells. Second, we will use a clinical treatment that reduces brain swelling. We expect that this will lessen swelling, and since cell volume is related to water content, perhaps facilitate cell shrinkage throughout the brain. We additionally expect any cell damage associated with CS will be amplified with this treatment. Overall, this project provides exciting and novel insight into the mechanism of cellular shrinkage and its benefit and harm.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
449480
Name
Kung Tiffany F
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cell Shrinkage as a Result of Raised Intracranial Pressure after Intracerebral Hemorrhage
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Shrinkage; Compliance Mechanisms; Csf Drainage; External Ventricular Drainage; Functional Outcome; Hypertonic Saline; Intracerebral Hemorrhage; Pre-Clinical Research; Raised Intracranial Pressure; Stroke
Abstract
Intracerebral hemorrhage (ICH) is a devastating stroke subtype in which a blood vessel ruptures in the brain. Normally, the skull has three components: brain, blood, and cerebrospinal fluid (CSF), which must remain in equilibrium to maintain brain health. However, ICH results in bleeding and swelling in the brain. To maintain equilibrium after ICH, blood and CSF can be ""pushed"" out of the skull, reducing the amount of pressure. These ""compliance mechanisms"" help maintain normal intracranial pressure (ICP). When these mechanisms fail, ICP elevations can worsen outcome and increase the risk of death. Previously, brain tissue was not thought to play a role in ICP compensation. However, we have recently shown cell shrinkage (a decrease in the size of brain cells) following ICH, and we hypothesize that this is a previously uncharacterized compliance mechanism to blunt rises in ICP. Importantly, we have found evidence that this cell shrinkage can harm brain cells. Our goal is to test whether two clinically used methods of ICP reduction after stroke still result in cell shrinkage, and their impact on cellular health. First, we will reduce ICP with one clinical treatment. Since reducing ICP will reduce the pressure on shrinking cells, we expect to see less cell shrinkage after this treatment, and perhaps lessen or prevent injury to brain cells. Second, we will use a clinical treatment that reduces brain swelling. We expect that this will lessen swelling, and since cell volume is related to water content, perhaps facilitate cell shrinkage throughout the brain. We additionally expect any cell damage associated with CS will be amplified with this treatment. Overall, this project provides exciting and novel insight into the mechanism of cellular shrinkage and its benefit and harm.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kung, Tiffany F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~